Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MRNA-seq of human cells lines derived from Papillary thyroid carcinoma (TPC1) transfected with siRNA against BHLHE40 (DEC1) or with scramble control siRNA

ABSTRACT: mRNA-seq of human cells lines derived from Papillary thyroid carcinoma (TPC1) transfected with siRNA against BHLHE40 (DEC1) or with scramble control siRNA

PROVIDER: PRJEB24470 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2259204_1.fastq.gz	Fastqsanger.gz
	ERR2259204_2.fastq.gz	Fastqsanger.gz
	ERR2259205_1.fastq.gz	Fastqsanger.gz
	ERR2259205_2.fastq.gz	Fastqsanger.gz
	ERR2259206_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

mRNA-seq of human cells lines derived from Papillary thyroid carcinoma (TPC1) transfected with siRNA against BHLHE40 (DEC1) or with scramble control siRNA

Project description:The goal of this experiment was to identify genes under the regulation of the bHLh transcription factor Dec1 in thyroid cancer. To this end silencing of Dec1 by siRna transfection in TPC1 cells was performed and changes in gene expression analyzed by mRNA-seq

2018-09-03 | E-MTAB-6394 | biostudies-arrayexpress

Expression analysis of C2C12 cells treated with scramble siRNA or siRNA directed against Brd4

Project description:We transfected C2C12 cells with 100nM of scrambled siRNA scramble and an siRNA directed against Brd4. Cells were harvested at 48h post-transfection and RNAseq was performed with polyA selection

2022-09-28 | GSE141777 | GEO

Expression analysis of C2C12 cells treated with scramble siRNA or siRNA directed against Fndc1

Project description:We transfected C2C12 cells with 100nM of scrambled siRNA scramble and an siRNA directed against Fndc1. Cells were harvested at 48h post-transfection and RNAseq was performed with polyA selection

2024-08-17 | GSE217125 | GEO

Papillary thyroid cancer cell lines treated with Y15

Project description:3 papillary thyroid cancer cell lines were compared, treated with Y15 to untreated. 1 million cells of each papillary thyroid cell line (TPC1, K1, BCPAP) were plated, treated 24 hours later with 10uM Y15, and collected 24 hours later by trypsinization.

2014-03-06 | E-GEOD-55603 | biostudies-arrayexpress

Expression data from mouse differentiated Bhlhe40-GFPneg and Bhlhe40-GFPpos TH17 cells

Project description:Microarray data on TH17 cells from Bhlhe40-GFP reporter mice We used microarrays to detail the global programme of gene expression in polarized Bhlhe40-GFPneg and Bhlhe40-GFPpos TH17 cells Purified naÃ¯ve CD4 T cells from spleen were polarized under TH17 condition in vitro. On day 4, cells were stimulated with PMA and ionomycin, and sorted by their Bhlhe40-GFP expression prior to microarray analysis

2016-01-04 | E-GEOD-75407 | biostudies-arrayexpress

Altered gene expression by hsa_circ_0000839 in papillary thyroid cancer cells

Project description:The expression level of hsa_circ_0000839 was downregulated in papillary thyroid cancer. However, its functions were still unclear. To explore the functions of hsa_circ_0000839, we analyzed the gene expression in TPC1 cells with or without hsa_circ_0000839 silencing.

2020-11-05 | GSE160796 | GEO

Gene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

Project description:We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. Gene expression changes were evaluated comparing cells treated with the inhibitor for 24 hours versus cells treated with DMSO for 24 hours.

2014-06-30 | GSE49414 | GEO

microRNA expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1

Project description:We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. microRNA expression changes were evaluated comparing cells treated with the inhibitor fo 24 hours versus cells treated with DMSO for 24 hours.

2014-06-30 | GSE49401 | GEO

Expression analysis of C2C12 cells treated with scramble siRNA or siRNA directed against Brd4

Project description:Expression analysis of C2C12 cells treated with scramble siRNA or siRNA directed against Brd4

| PRJNA594708 | ENA

Expression analysis of C2C12 cells treated with scramble siRNA or siRNA directed against Fndc1

Project description:Expression analysis of C2C12 cells treated with scramble siRNA or siRNA directed against Fndc1

| PRJNA896977 | ENA